X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (25949) 25949
Magazine Article (113) 113
Dissertation (79) 79
Book Chapter (29) 29
Publication (26) 26
Book / eBook (22) 22
Conference Proceeding (16) 16
Government Document (7) 7
Newsletter (5) 5
Streaming Video (3) 3
Web Resource (3) 3
Journal / eJournal (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (24523) 24523
humans (24500) 24500
science & technology (19159) 19159
life sciences & biomedicine (18955) 18955
middle aged (18850) 18850
postmenopause (18033) 18033
aged (12242) 12242
adult (6566) 6566
postmenopausal women (5670) 5670
risk factors (5606) 5606
obstetrics & gynecology (5228) 5228
menopause (4983) 4983
oncology (3552) 3552
postmenopause - physiology (3366) 3366
abridged index medicus (3156) 3156
endocrinology & metabolism (3149) 3149
breast cancer (3068) 3068
health aspects (2960) 2960
aged, 80 and over (2822) 2822
estrogen replacement therapy (2773) 2773
postmenopause - blood (2594) 2594
hormone replacement therapy (2562) 2562
body mass index (2466) 2466
prospective studies (2413) 2413
women (2305) 2305
osteoporosis (2208) 2208
breast neoplasms - drug therapy (2088) 2088
bone density (2033) 2033
treatment outcome (1940) 1940
estrogen (1935) 1935
premenopause (1926) 1926
cross-sectional studies (1869) 1869
double-blind method (1812) 1812
case-control studies (1793) 1793
research (1752) 1752
postmenopause - drug effects (1736) 1736
male (1645) 1645
general & internal medicine (1643) 1643
medicine, general & internal (1635) 1635
surveys and questionnaires (1524) 1524
analysis (1500) 1500
follow-up studies (1495) 1495
cohort studies (1479) 1479
public, environmental & occupational health (1451) 1451
postmenopause - metabolism (1450) 1450
medicine & public health (1449) 1449
age factors (1437) 1437
time factors (1411) 1411
breast neoplasms - pathology (1400) 1400
hormone therapy (1348) 1348
breast neoplasms - epidemiology (1259) 1259
cancer (1245) 1245
geriatrics & gerontology (1243) 1243
women's health (1240) 1240
estrogen replacement therapy - adverse effects (1167) 1167
estradiol - blood (1142) 1142
nutrition & dietetics (1133) 1133
womens health (1101) 1101
physiological aspects (1056) 1056
incidence (1043) 1043
bone mineral density (1042) 1042
cardiovascular system & cardiology (1041) 1041
ultrasonography (1026) 1026
retrospective studies (1021) 1021
estradiol - administration & dosage (1017) 1017
epidemiology (1002) 1002
animals (1000) 1000
bones (988) 988
obesity (963) 963
exercise (961) 961
risk assessment (958) 958
post-menopause (950) 950
hormones (944) 944
tamoxifen - therapeutic use (943) 943
absorptiometry, photon (934) 934
care and treatment (932) 932
internal medicine (931) 931
diet (926) 926
estrogens (922) 922
prognosis (895) 895
biomarkers - blood (885) 885
quality of life (883) 883
antineoplastic agents, hormonal - therapeutic use (859) 859
randomized controlled trials as topic (842) 842
bone density - drug effects (810) 810
density (782) 782
risk (782) 782
prevalence (776) 776
lipids - blood (773) 773
postmenopausal (752) 752
bone density - physiology (730) 730
odds ratio (711) 711
breast neoplasms - metabolism (695) 695
postmenopause - psychology (695) 695
administration, oral (692) 692
endometrium - pathology (692) 692
estradiol (692) 692
aging (691) 691
regression analysis (685) 685
logistic models (678) 678
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (19) 19
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Gerstein Science - Not Returned (1) 1
Gerstein Science - Periodical Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
New College (Ivey) - Stacks (1) 1
Scarborough Hospital - Birchmount (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (24788) 24788
Spanish (327) 327
Portuguese (261) 261
French (246) 246
German (237) 237
Russian (194) 194
Chinese (174) 174
Japanese (167) 167
Korean (145) 145
Polish (138) 138
Italian (120) 120
Turkish (45) 45
Bulgarian (38) 38
Czech (28) 28
Hungarian (27) 27
Swedish (25) 25
Danish (22) 22
Croatian (18) 18
Dutch (18) 18
Serbian (13) 13
Hebrew (12) 12
Norwegian (11) 11
Finnish (9) 9
Persian (8) 8
Romanian (6) 6
Slovak (5) 5
Ukrainian (3) 3
Arabic (2) 2
Bosnian (2) 2
Indonesian (2) 2
Lithuanian (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of clinical oncology, ISSN 1527-7755, 11/2009, Volume 27, Issue 33, pp. 5538 - 5546
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial... 
Life Sciences & Biomedicine | Oncology | Science & Technology | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article
Journal Article
BMC genomics, ISSN 1471-2164, 2014, Volume 15, Issue 1, pp. 1165 - 1165
Journal Article
Journal Article